• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MDT PUERTO RICO OPERATIONS CO, MED REL CATALYFT¿ PL EXPANDABLE INTERBODY SYSTEM; INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MDT PUERTO RICO OPERATIONS CO, MED REL CATALYFT¿ PL EXPANDABLE INTERBODY SYSTEM; INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT, Back to Search Results
Model Number 6069116
Medical Device Problem Code Mechanics Altered (2984)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/30/2025
Type of Reportable Event Serious Injury
Event or Problem Description
Information was received from healthcare provider (hcp) via a manufacturer representative regarding a patient having spinal therapy.It was reported that six months after a spinal procedure the cage was found to have folded back into its original position, there was a loss of lordosis, and the cage had closed by itself.No patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
D4: lot number is unknown h6: neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
The type of procedure involved during the event was solera therapy.
 
Additional Manufacturer Narrative
B2: outcome attributed to adverse event is revision surgery and product explanted.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information was received from the manufacturer representative that the revision surgery was happened and implant was explanted on (b)(6) 2025.There was no patient complications after surgery.
 
Additional Manufacturer Narrative
H3: product analysis of product: 1030489-2025-02307-3, lot:1014876w visual and optical inspection confirmed the spacer threads have been damaged.Functional inspection confirmed the spacer was able to expand and collapse as intended.The damage to the spacer appears to be from implantation and removal process.Radiographic image review states, that the pre-operative mri indicates multi-level lumbar deformity and stenosis, while the post-operative x-ray shows l2-5 lumbar fusion with interbody grafts at l2-3, l3-4, and l4-5.The latest x-rays remain consistent with the previous findings until the most recent, which reveals a collapse of the l4-5 interbody graft compared to earlier images.Consequently, intra-operative fluoroscopy was used to revise the l4-5 interbody device and extend the fusion.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CATALYFT¿ PL EXPANDABLE INTERBODY SYSTEM
Common Device Name
INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT,
Manufacturer (Section D)
MDT PUERTO RICO OPERATIONS CO, MED REL
road 909, km. 0.4., barrio mar
humacao PR 00792
Manufacturer (Section G)
MDT PUERTO RICO OPERATIONS CO, MED REL
road 909, km. 0.4., barrio mar
humacao PR 00792
Manufacturer Contact
justin ellis
1800 pyramid place
memphis, TN 38132
7635265677
MDR Report Key22306118
Report Number1030489-2025-02307
Device Sequence Number8081260
Product Code MAX
UDI-Device Identifier00763000246853
UDI-Public(01)00763000246853(17)320405(10)1014876W
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K210425
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2025
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 10/07/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number6069116
Device Catalogue Number6069116
Device Lot Number1014876W
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/30/2025
Supplement Date Received by Manufacturer06/30/2025
08/01/2025
10/06/2025
Initial Report FDA Received Date06/23/2025
Supplement Report FDA Received Date07/24/2025
08/22/2025
10/07/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/05/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
Patient SexUnknown
Patient Weight90 KG
-
-